Author:
Tajfirouz Deena A.,Bhatti M. Tariq,Chen John J.
Publisher
Springer Science and Business Media LLC
Subject
Neurology (clinical),General Neuroscience
Reference59 articles.
1. Schluesener HJ, Sobel RA, Linington C, Weiner HL. A monoclonal antibody against a myelin oligodendrocyte glycoprotein induces relapses and demyelination in central nervous system autoimmune disease. J Immunol. 1987;139(12):4016–21.
2. Steinman L, Zamvil SS. How to successfully apply animal studies in experimental allergic encephalomyelitis to research on multiple sclerosis. Ann Neurol. 2006;60(1):12–21. https://doi.org/10.1002/ana.20913.
3. Berger T, Rubner P, Schautzer F, Egg R, Ulmer H, Mayringer I, et al. Antimyelin antibodies as a predictor of clinically definite multiple sclerosis after a first demyelinating event. N Engl J Med. 2003;349(2):139–45. https://doi.org/10.1056/NEJMoa022328.
4. • Jarius S, Paul F, Aktas O, Asgari N, Dale RC, de Seze J, et al. MOG encephalomyelitis: international recommendations on diagnosis and antibody testing. J Neuroinflamm. 2018;15(1):134. https://doi.org/10.1186/s12974-018-1144-2 This article provides recommendations regarding diagnosis and antibody testing based on the literature available as of 2018.
5. Weber MS, Derfuss T, Metz I, Bruck W. Defining distinct features of anti-MOG antibody associated central nervous system demyelination. Ther Adv Neurol Disord. 2018;11:1756286418762083. https://doi.org/10.1177/1756286418762083.
Cited by
48 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献